Mortality by causes in HIV-infected adults: comparison with the general population
- China reported 60% decrease in HIV-related mortality, yet far from overall goal. Smith, Stephen M. // Infectious Disease News;Jun2011, Vol. 24 Issue 6, p16
The article reports on a 60% reduction in HIV-related mortality from 2002 to 2009 and an increase in antiretroviral treatment coverage among those eligible for treatment in China.
- Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients. Ingle, Suzanne M.; May, Margaret T.; Gill, M. John; Mugavero, Michael J.; Lewden, Charlotte; Abgrall, Sophie; Fätkenheuer, Gerd; Reiss, Peter; Saag, Michael S.; Manzardo, Christian; Grabar, Sophie; Bruyand, Mathias; Moore, David; Mocroft, Amanda; Sterling, Timothy R.; D'Arminio Monforte, Antonella; Hernando, Victoria; Teira, Ramon; Guest, Jodie; Cavassini, Matthias // Clinical Infectious Diseases;Jul2014, Vol. 59 Issue 2, p287
Among HIV-infected patients who initiated antiretroviral therapy (ART), patterns of cause-specific death varied by ART duration and were strongly related to age, sex, and transmission risk group. Deaths from non-AIDS malignancies were much more frequent than those from cardiovascular...
- CD4 Decline Is Associated With Increased Risk of Cardiovascular Disease, Cancer, and Death in Virally Suppressed Patients With HIV. Helleberg, Marie; Kronborg, Gitte; Larsen, Carsten S.; Pedersen, Gitte; Pedersen, Court; Obel, Niels; Gerstoft, Jan // Clinical Infectious Diseases;Jul2013, Vol. 57 Issue 2, p314
We studied the clinical implications of CD4 decline among virally suppressed human immunodeficiency virus patients and found that the risk of cardiovascular disease, cancer, and death was substantially increased within 6 months after a major CD4 decline and moderately increased...
- Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy. Miller, Christopher J.; Baker, Jason V.; Bormann, Alison M.; Erlandson, Kristine M.; Huppler Hullsiek, Katherine; Justice, Amy C.; Neuhaus, Jacqueline; Paredes, Roger; Petoumenos, Kathy; Wentworth, Deborah; Winston, Alan; Wolfson, Julian; Neaton, James D. // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1
Background: Non-AIDS conditions such as cardiovascular disease and non-AIDS defining cancers dominate causes of morbidity and mortality among persons with HIV on suppressive combination antiretroviral therapy. Accurate estimates of disease incidence and of risk factors for these conditions are...
- A comment on "Does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in Indian patients?: A cross sectional study". Raina, S. K. // Journal of Postgraduate Medicine;Apr-Jun2014, Vol. 60 Issue 2, p226
A letter to the editor regarding the article "Does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in Indian patients?: A cross sectional study" published in a previous issue is presented.
- Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population. Morten Baekken; Ingrid Os; Leiv Sandvik; Olav Oektedalen // Nephrology Dialysis Transplantation;Oct2008, Vol. 23 Issue 10, p3130
Background. The survival of human immunodeficiency virus (HIV)-infected patients has increased significantly since the introduction of combination antiretroviral therapy, leading to the development of important long-term complications including cardiovascular disease (CVD) and renal disease....
- Universal testing + universal treatment = big impact. // HIV Australia;2007, Vol. 7 Issue 2, p7
The article reports on the impact of universal testing for HIV and the immediate antiretroviral therapy (ART) for those found to be positive. It states that HIV testing and the quick treatment with ART could reduce HIV incidence and mortality to less than one case in every 1000 people every year...
- Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain. Estrada, Vicente; Bernardino, José Ignacio; Masi, Mar; Iribarren, José Antonio; Ortega, Alejandra; Lozano, Fernando; Miralles, Celia; Olalla, Julián; Santos, Jesús; Elías, María Jesús Pérez; Domingo, Pere; Cruz, Arturo Fernández // HIV Clinical Trials (Thomas Land Publishers Incorporated);04/01/2015, p57
No abstract available.
- Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study. Panos, George; Samonis, George; Alexiou, Vangelis G.; Kavarnou, Garyfallia A.; Charatsis, Gerasimos; Falagas, Matthew E. // Current HIV Research;May2008, Vol. 6 Issue 3, p257
HAART has substantially decreased mortality and morbidity among HIV-infected patients. We retrospectively analyzed morbidity and mortality in a cohort of HIV-infected adult patients with prolonged and frequent follow up (1987-2006). The study was divided in pre-HAART and HAART period for...